win 52035 has been researched along with isoxazoles in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badger, J; Dutko, FJ; Fancher, M; Heinz, BA; McKinlay, MA; Rossmann, MG; Rueckert, RR; Shepard, DA; Smith, TJ | 1 |
| Hadfield, AT; Heinz, BA; Kim, KH; Kremer, MJ; Minor, I; Oliveira, MA; Pevear, DC; Rossmann, MG; Rueckert, RR; Shepard, D | 1 |
| Heinz, BA; Rueckert, RR; Shepard, DA | 1 |
| Lee, WM; Mosser, AG; Rueckert, RR; Wang, W | 1 |
| Blaas, D; Kenndler, E; Nizet, S; Okun, VM | 1 |
| Lee, WM; Wang, W | 1 |
| Bates, ME; Bertics, PJ; Cronan, M; Guar, L; Hall, DJ; Korpi, N | 1 |
7 other study(ies) available for win 52035 and isoxazoles
| Article | Year |
|---|---|
Genetic and molecular analyses of spontaneous mutants of human rhinovirus 14 that are resistant to an antiviral compound.
Topics: Antiviral Agents; Dose-Response Relationship, Drug; Drug Resistance, Microbial; HeLa Cells; Humans; Isoxazoles; Models, Molecular; Molecular Conformation; Molecular Structure; Mutation; Oxazoles; Rhinovirus; Viral Plaque Assay | 1989 |
Structural studies on human rhinovirus 14 drug-resistant compensation mutants.
Topics: Antiviral Agents; Binding, Competitive; Capsid; Crystallography, X-Ray; Drug Resistance, Microbial; Humans; Intercellular Adhesion Molecule-1; Isoxazoles; Mutation; Protein Conformation; Receptors, Virus; Rhinovirus; Viral Proteins | 1995 |
WIN 52035-2 inhibits both attachment and eclipse of human rhinovirus 14.
Topics: Antiviral Agents; Capsid; Capsid Proteins; Drug Resistance, Microbial; HeLa Cells; Hot Temperature; Humans; In Vitro Techniques; Isoxazoles; Mutation; Rhinovirus; RNA, Viral; Virion; Virus Replication | 1993 |
WIN 52035-dependent human rhinovirus 16: assembly deficiency caused by mutations near the canyon surface.
Topics: Antiviral Agents; Humans; Isoxazoles; Models, Molecular; Mutation; Rhinovirus; Virion; Virus Assembly | 1998 |
Kinetics of thermal denaturation of human rhinoviruses in the presence of anti-viral capsid binders analyzed by capillary electrophoresis.
Topics: Antiviral Agents; Benzoates; Capsid; Electrophoresis, Capillary; Heating; HeLa Cells; Humans; Isoelectric Point; Isoxazoles; Kinetics; Pyrroles; Rhinovirus; Temperature; Time Factors | 2002 |
Human rhinovirus type 16: mutant V1210A requires capsid-binding drug for assembly of pentamers to form virions during morphogenesis.
Topics: Capsid; DNA, Complementary; HeLa Cells; Humans; Isoxazoles; Mutation; Polyproteins; Rhinovirus; RNA, Viral; Viral Proteins; Virion; Virus Assembly; Virus Replication | 2003 |
The role of p38 MAPK in rhinovirus-induced monocyte chemoattractant protein-1 production by monocytic-lineage cells.
Topics: Activating Transcription Factor 2; Antibodies, Blocking; Antiviral Agents; Cell Line, Tumor; Cell Lineage; Cells, Cultured; Chemokine CCL2; Cyclic AMP Response Element-Binding Protein; HeLa Cells; Humans; Hydrogen-Ion Concentration; I-kappa B Proteins; Intercellular Adhesion Molecule-1; Isoxazoles; Macrophages, Alveolar; Monocytes; NF-KappaB Inhibitor alpha; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Rhinovirus; RNA, Messenger; Transcription Factors | 2005 |